Kane Biotech Inc. in partnership with ProgenaCare Global LLP announced the launch of the newly rebranded revyve Antimicrobial Wound Gel (formerly coactiv+? Antimicrobial Wound Gel). The product rebranding is being unveiled as part of Kane's participation in the Symposium on Advanced Wound Care (SAWC) Fall forum.

The conference will take place on November 2-5, 2023 in Las Vegas, Nevada and is intended to connect the entire wound care team fostering inclusivity, innovation and interdisciplinary collaboration. During this conference, Kane Biotech and ProgenaCare will present along with other important voices in the Biotech and Wound Care sectors. Kane's revyve Antimicrobial Wound Gel is a combination of its patented coactiv+?

technology and PHMB, paired with a non-ionic pluronic surfactant with thermo-gelling properties. The combination of these three components provides for a moist environment best suited for wound healing, with effective antimicrobial activity in an easy-to-use gel that is optimized for sensitive wounds.